My bookmarksSign up free

Commission Implementing Regulation (EU) 2022/1185 of 8 July 2022 granting a Union authorisation for the biocidal product family ‘Contec Hydrogen Peroxide Biocidal Product Family’ (Text with EEA relevance)

Commission Implementing Regulation (EU) 2022/1185 of 8 July 2022 granting a Union authorisation for the biocidal product family ‘Contec Hydrogen Peroxide Biocidal Product Family’ (Text with EEA relevance)

Implementing Regulation (EU) 2022/1185 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

A Union authorisation with authorisation number EU-0027735-0000 is granted to Contec Europe for the making available on the market and use of the biocidal product family ‘Contec Hydrogen Peroxide Biocidal Product Family’ in accordance with the summary of the biocidal product characteristics set out in the Annex. The Union Authorisation is valid from 31 July 2022 to 30 June 2032.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

Summary of product characteristics for a biocidal product family

ANNEXSupplementary provisions

ANNEX Summary of product characteristics for a biocidal product family Contec Hydrogen Peroxide Biocidal Product Family Product type 2 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) Authorisation number: EU-0027735-0000 R4BP asset number: EU-0027735-0000 PART I FIRST INFORMATION LEVEL 1.    ADMINISTRATIVE INFORMATION 1.1.    Family name Name Contec Hydrogen Peroxide Biocidal Product Family 1.2.    Product type(s) Product type(s) PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) 1.3.    Authorisation holder Name and address of the authorisation holder Name Contec Europe Address Zl Du Prat Avenue Paul Duplaix, 56000 Vannes France Authorisation number EU-0027735-0000 R4BP asset number EU-0027735-0000 Date of the authorisation 31 July 2022 Expiry date of the authorisation 30 June 2032 1.4.    Manufacturer(s) of the biocidal products Name of manufacturer Contec Inc., Address of manufacturer 525 Locust Grove,, 29303 Spartanburg, United States Location of manufacturing sites Unit 6A, Wansbeck Business Park, Rotary Parkway,, NE63 8QW Ashington, United Kingdom 1.5.    Manufacturer(s) of the active substance(s) Active substance Hydrogen peroxide Name of manufacturer Solvay Chemicals International Address of manufacturer Rue Ransbeek 310,, 1120 Brussels, Belgium Location of manufacturing sites Rue Solvay 39,, B-5190 Jemeppe-sur-Sambre, Belgium Via Piave 6, Rosignano Solvay,, I-57013 Livorno, Italy Köthensche Strasse 1-3,, D06406 Bernburg, Germany Baronet Road,, WA4 6HA Warrington, United Kingdom Yrjönojantie 2,, 45910 Voikkaa, Finland Rua Eng. Clement Dumoulin,, P-2625-106 Povoa de Santa Iria, Portugal 2.    PRODUCT FAMILY COMPOSITION AND FORMULATION 2.1.    Qualitative and quantitative information on the composition of the family Common name IUPAC name Function CAS number EC number Content (%) Min Max Hydrogen peroxide   Active Substance 7722-84-1 231-765-0 6,67 6,67 2.2.    Type(s) of formulation Formulation(s) AL - Any other liquid PART II SECOND INFORMATION LEVEL - META SPC(S) META SPC 1 1.    META SPC 1 ADMINISTRATIVE INFORMATION 1.1.    Meta SPC 1 identifier Identifier meta SPC 1 1.2.    Suffix to the authorisation number Number 1-1 1.3.    Product type(s) Product type(s) PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) 2.    META SPC 1 COMPOSITION 2.1.    Qualitative and quantitative information on the composition of the meta SPC 1 Common name IUPAC name Function CAS number EC number Content (%) Min Max Hydrogen peroxide   Active Substance 7722-84-1 231-765-0 6,67 6,67 2.2.    Type(s) of formulation of the meta SPC 1 Formulation(s) AL - Any other liquid 3.    HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 1 Hazard statements Causes serious eye irritation. Precautionary statements Wash hands thoroughly after handling. Wear eye protection/face protection. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists:Get medical attention. If eye irritation persists:Get medical advice. 4.    AUTHORISED USE(S) OF THE META SPC 1 4.1.    Use description Table 1. Use # 1 – Use #1 - Application by trigger spray onto a suitable cleanroom wipe to distribute onto the inner surface of isolators and Restricted Access Barrier Systems ('RABS') Product type PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) Where relevant, an exact description of the authorised use / Target organism(s) (including development stage) Scientific name: / Common name: Bacteria Development stage: / Scientific name: / Common name: Yeasts Development stage: / Scientific name: / Common name: Fungi Development stage: / Field(s) of use Indoor In isolators and RABS positioned in cleanrooms: disinfection of hard/non-porous surfaces. Not for use in healthcare. Application method(s) Method: Spraying the product onto a suitable cleanroom wipe used to distribute the product on the surface. Detailed description: / Application rate(s) and frequency Application Rate: / Dilution (%): No dilution - product is ready to use ('RTU') Number and timing of application: Ready-to-use product active against bacteria in 15 min and against yeasts and fungi in 30 min contact time at room temperature (~ 20 °C). Application frequency is specific to the user’s site and requirements. Category(ies) of users Professional Pack sizes and packaging material 1L adjustable trigger spray high density polyethylene ('HDPE') bottle sealed with a polyethylene outer bag. 4.1.1.    Use-specific instructions for use Spray the product onto a cleanroom wipe inside the isolator or RABS and use to apply the product to the surface to be disinfected. Ensure the entire surface is visibly wet for the contact time: 15 minutes for bacteria and 30 minutes for yeasts and fungi. Do not use more than 50 ml product/m 2 . Uniform distribution of the biocidal product should be ensured. For visibly soiled surfaces, cleaning prior to the disinfection is required. 4.1.2.    Use-specific risk mitigation measures Avoid hand to eye contact. 4.1.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See section General directions for use. 4.1.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See section General directions for use. 4.1.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See section General directions for use. 4.2.    Use description Table 2. Use # 2 – Use #2 - Application by pouring into a container and using a suitable cleanroom wipe or mop to distribute onto the inner surface of isolators and RABS Product type PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) Where relevant, an exact description of the authorised use / Target organism(s) (including development stage) Scientific name: / Common name: Bacteria Development stage: / Scientific name: / Common name: Yeasts Development stage: / Scientific name: / Common name: Fungi Development stage: / Field(s) of use Indoor In isolators and RABS positioned in cleanrooms: disinfection of hard/non-porous surfaces. Not for use in healthcare. Application method(s) Method: Pouring the product into a suitable container and then distributing it on the surface with a suitable cleanroom wipe or mop. Detailed description: / Application rate(s) and frequency Application Rate: / Dilution (%): No dilution - product is RTU. Number and timing of application: Ready-to-use product active against bacteria in 15 min and against yeasts and fungi in 30 min contact time at room temperature (~ 20 °C). Application frequency is specific to the user’s site and requirements. Category(ies) of users Professional Pack sizes and packaging material 0.5L, 1 L and 5L tamper evident cap HDPE bottle sealed with a polyethylene outer bag. 4.2.1.    Use-specific instructions for use Pour the product into a suitable container inside the isolator or RABS and use a cleanroom wipe or mop to apply the product to the surface to be disinfected. Ensure the entire surface is visibly wet for the contact time: 15 minutes for bacteria and 30 minutes for yeasts and fungi. Do not use more than 50 ml product/m 2 . Uniform distribution of the biocidal product should be ensured. For visibly soiled surfaces, cleaning prior to the disinfection is required. 4.2.2.    Use-specific risk mitigation measures Avoid hand to eye contact. 4.2.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See section General directions for use. 4.2.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See section General directions for use. 4.2.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See section General directions for use. 4.3.    Use description Table 3. Use # 3 – Use #3 - Application by trigger spray onto a suitable cleanroom wipe to distribute onto the surface of cleanrooms Product type PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) Where relevant, an exact description of the authorised use / Target organism(s) (including development stage) Scientific name: / Common name: Bacteria Development stage: / Scientific name: / Common name: Yeasts Development stage: / Scientific name: / Common name: Fungi Development stage: / Field(s) of use Indoor Disinfection of hard, non-porous surfaces in cleanrooms. Not for use in healthcare. Application method(s) Method: Spray the product onto a suitable cleanroom wipe used to distribute the product on the surface. Detailed description: / Application rate(s) and frequency Application Rate: / Dilution (%): No dilution - product is RTU. Number and timing of application: Ready-to-use product active against bacteria in 15 min and against yeasts and fungi in 30 min contact time at room temperature (~ 20 °C). Application frequency is specific to the user’s site and requirements. Category(ies) of users Professional Pack sizes and packaging material 1L adjustable trigger spray HDPE bottle sealed with a polyethylene outer bag. 4.3.1.    Use-specific instructions for use Spray the product onto a cleanroom wipe and use to apply the product to the surface to be disinfected in the cleanroom. Ensure the entire surface is visibly wet for the contact time: 15 minutes for bacteria and 30 minutes for yeasts and fungi. Do not use more than 50 ml product/m 2 . Uniform distribution of the biocidal product should be ensured. For visibly soiled surfaces, cleaning prior to the disinfection is required. 4.3.2.    Use-specific risk mitigation measures The product must only be applied for disinfection of small surfaces. The use of eye protection during handling of the product is mandatory. For use in cleanrooms, adequate technical/engineering controls to remove airborne residues is mandatory (e.g. room ventilation or Local Exhaust Ventilation ('LEV')). A minimum ventilation rate of 360/hr is mandatory for cleanrooms where the product is applied. 4.3.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See section General directions for use. 4.3.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See section General directions for use. 4.3.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See section General directions for use. 4.4.    Use description Table 4. Use # 4 – Use #4 - Application by pouring into a container and using a suitable cleanroom wipe or mop to distribute onto the surface of cleanrooms Product type PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) Where relevant, an exact description of the authorised use / Target organism(s) (including development stage) Scientific name: / Common name: Bacteria Development stage: / Scientific name: / Common name: Yeasts Development stage: / Scientific name: / Common name: Fungi Development stage: / Field(s) of use Indoor Disinfection of hard, non-porous surfaces in cleanrooms. Not for use in healthcare. Application method(s) Method: Pouring the product into a suitable container and then distributing it on the surface with a suitable cleanroom wipe or mop Detailed description: / Application rate(s) and frequency Application Rate: / Dilution (%): No dilution - product is RTU. Number and timing of application: Ready-to-use product active against bacteria in 15 min and against yeasts and fungi in 30 min contact time at room temperature (~ 20 °C). Application frequency is specific to the user’s site and requirements. Category(ies) of users Professional Pack sizes and packaging material 0.5L, 1L and 5L tamper evident cap HDPE bottle sealed with a polyethylene outer bag. 4.4.1.    Use-specific instructions for use Pour the product into a suitable container and use a cleanroom wipe or mop to apply the product to the surface to be disinfected in the cleanroom. Ensure the entire surface is visibly wet for the contact time: 15 minutes for bacteria and 30 minutes for yeasts and fungi. Do not use more than 50 ml product/m 2 . Uniform distribution of the biocidal product should be ensured. For visibly soiled surfaces, cleaning prior to the disinfection is required. 4.4.2.    Use-specific risk mitigation measures Pouring of product shall be done in ventilated rooms only (with min. 3 air change/h). The use of eye protection during handling of the product is mandatory. For use in cleanrooms, adequate technical/engineering controls to remove airborne residues is mandatory (e.g. room ventilation or LEV. A minimum ventilation rate of 360/hr is mandatory for cleanrooms where the product is applied. If the product is applied by wiping, the disinfection must be limited to small area. When using the product with a mop to disinfect floors or other large surfaces in cleanrooms, additional risk mitigation measures must be considered: — Use of respiratory protective equipment (RPE) providing a protection factor of 10 is mandatory for the professional user and all other personnel within the room. At least a powered air purifying respirator with helmet/hood/mask (TH1/TM1), or a half/full mask with combination filter gas/P2 is required (filter type (code letter, colour) to be specified by the authorisation holder within the product information). — All personnel must leave the room after mopping. — Technical or engineering controls to remove airborne residues is mandatory (e.g. ventilation or LEV) before professionals are permitted to enter into treated areas after large surface disinfection. Monitor the air concentration and ensure that the limit value (1.25 mg/m 3 ) is not exceeded when professionals re-enter the area. 4.4.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See section General directions for use. 4.4.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See section General directions for use. 4.4.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See section General directions for use. 5.    GENERAL DIRECTIONS FOR USE   ( 1 ) OF THE META SPC 1 5.1.    Instructions for use See Use-specific instructions for use. 5.2.    Risk mitigation measures Used wipes must be disposed in a closed container. 5.3.    Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment DIRECT/INDIRECT EFFECTS Causes serious eye irritation. No other health injuries are known or expected under normal use. FIRST AID INSTRUCTIONS IF INHALED: If symptoms occur, call a POISON CENTRE or a doctor. IF SWALLOWED: Rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call a POISON CENTRE or a doctor. IF ON SKIN: Wash skin with water. If symptoms occur, call a POISON CENTRE or a doctor. IF IN EYES: Rinse with water. Remove contact lenses, if present and easy to do. Continue rinsing for 5 minutes. Call a POISON CENTRE or a doctor. EMERGENCY MEASURES TO PROTECT THE ENVIRONMENT Avoid release to the environment. 5.4.    Instructions for safe disposal of the product and its packaging Disposal of this packaging should at all times comply with the waste disposal legislation and any regional local authority requirements. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. 5.5.    Conditions of storage and shelf-life of the product under normal conditions of storage Store in a dry well ventilated area and protect from damage and direct sunlight. Store in properly designed bulk storage tanks or in original vented container. Keep container tightly closed. Do not freeze. Do not store at temperature above 30°C. The shelf-life: 24 months. 6.    OTHER INFORMATION Not relevant. 7.    THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 1 7.1.    Trade name(s), authorisation number and specific composition of each individual product Trade name(s) Contec HydroPure Market area: EU Contec Sterile HydroPure Market area: EU Authorisation number EU-0027735-0001 1-1 Common name IUPAC name Function CAS number EC number Content (%) Hydrogen peroxide   Active Substance 7722-84-1 231-765-0 6,67 ( 1 )   Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 1.

Other acts of the same type
Regulation (EU) 2021/1134 of the European Parliament and of the Council of 7 July 2021 amending Regulations (EC) No 767/2008, (EC) No 810/2009, (EU) 2016/399, (EU) 2017/2226, (EU) 2018/1240, (EU) 2018/1860, (EU) 2018/1861, (EU) 2019/817 and (EU) 2019/1896 of the European Parliament and of the Council and repealing Council Decisions 2004/512/EC and 2008/633/JHA, for the purpose of reforming the Visa Information SystemRegulation (EU) 2021/1139 of the European Parliament and of the Council of 7 July 2021 establishing the European Maritime, Fisheries and Aquaculture Fund and amending Regulation (EU) 2017/1004Regulation (EU) 2021/1147 of the European Parliament and of the Council of 7 July 2021 establishing the Asylum, Migration and Integration FundRegulation (EU) 2021/1148 of the European Parliament and of the Council of 7 July 2021 establishing, as part of the Integrated Border Management Fund, the Instrument for Financial Support for Border Management and Visa PolicyRegulation (EU) 2021/1149 of the European Parliament and of the Council of 7 July 2021 establishing the Internal Security FundRegulation (EU) 2021/1150 of the European Parliament and of the Council of 7 July 2021 amending Regulations (EU) 2018/1862 and (EU) 2019/818 as regards the establishment of the conditions for accessing other EU information systems for the purposes of the European Travel Information and Authorisation SystemRegulation (EU) 2021/1151 of the European Parliament and of the Council of 7 July 2021 amending Regulations (EU) 2019/816 and (EU) 2019/818 as regards the establishment of the conditions for accessing other EU information systems for the purposes of the European Travel Information and Authorisation SystemRegulation (EU) 2021/1152 of the European Parliament and of the Council of 7 July 2021 amending Regulations (EC) No 767/2008, (EU) 2017/2226, (EU) 2018/1240, (EU) 2018/1860, (EU) 2018/1861 and (EU) 2019/817 as regards the establishment of the conditions for accessing other EU information systems for the purposes of the European Travel Information and Authorisation SystemRegulation (EU) 2021/1153 of the European Parliament and of the Council of 7 July 2021 establishing the Connecting Europe Facility and repealing Regulations (EU) No 1316/2013 and (EU) No 283/2014 (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/1686 of 7 July 2021 amending Delegated Regulation (EU) 2016/161 as regards the evaluation of notifications by national competent authorities to the Commission and the inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/2088 of 7 July 2021 amending Annexes II, III and IV to Regulation (EU) 2019/1009 of the European Parliament and of the Council for the purpose of adding pyrolysis and gasification materials as a component material category in EU fertilising products (Text with EEA relevance)Commission Regulation (EU) 2021/1110 of 6 July 2021 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, bixafen, fenazaquin, spinetoram, tefluthrin and thiencarbazone-methyl in or on certain products (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next